The rise in the number of chronic obstructive pulmonary disease patients (COPD), TB, asthma, and pneumonia cases remains the major driver of the industry. Chronic respiratory diseases are chronic diseases that affect the airways and other parts of the lungs. Respiratory symptoms are among the major causes of consultation with doctors and physicians in primary health care centers. Some of the major preventable chronic respiratory disorders are asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, sleep apnea, and tuberculosis (principally, multi-drug resistant tuberculosis). Chronic respiratory diseases affect more than one billion people, globally, as per the Global Asthma report, 2018. Asthma is one of the largest contributors to this figure, affecting children, adults, and elderly people. There is a high prevalence of severe asthma in the emerging markets of MEA and Latin America, compared to the mid-range prevalence in North America, Europe, and Asia-Pacific. More recently, the COVID-19 outbreak has also increased the demand for respiratory devices like Ventilators.
Moreover, the technological advances, increasing portability, and ease of operation of devices are fueling the expansion of respiratory devices in home and alternate care settings, across the world. In addition, government and non-profit initiatives, such as the global initiative for asthma (GINA), awareness programs, and funding research studies have influenced the industry.
Key Market Trends
Therapeutic Devices are Expected to grow fastest during the forecast period
Recently, therapeutic devices like Vetilators have been in high demand due to outbreak of COVID-19. A ventilator is a machine that provides mechanical ventilation by moving breathable air into and out of the lungs, to deliver breaths to a patient who is physically unable to breathe, or breathing insufficiently. Modern ventilators are computerized microprocessor-controlled machines, but patients can also be ventilated with a simple, hand-operated bag valve mask. Ventilators are chiefly used in intensive-care medicine, home care, and emergency medicine and in anesthesiology.
Outbreak of COVID-19 has been global and enourmous. As per Worldometer data, the total number of cases of COVID-19 increased from 11,950 in January 2020 to 86,604 in February 2020 to 859,798 by the end of March 2020. As of 12th April, 2020, there are a total of 1,852,365 globally. The pandemic has created a need for ventilators, especially for elderly, for therapeutic assistance. This is exepted to boost the market grwoth.
North America Region Holds the Largest Market Share of Respiratory Devices Market Market Currently and is Believed to Follow the Same Trend over the Forecast Period
North America accounts for the largest share of the market studied. This can be primarily attributed to the increasing prevalence of respiratory diseases. According to the data published by the World Health Organization (WHO), the Global Burden of Disease Study reported a prevalence of 251 million cases of Chronic Obstructive Pulmonary Disease (COPD) globally in 2016. Moreover, the burden of COVID-19 outbreak was enormous.
The presence of major players in the region, such as GE Healthcare, Medtronic, and ResMed Inc., are also augmenting the growth of the market.
The respiratory devices market consists of several major players. The companies are implementing certain strategic initiatives, such as a merger, new product launch, acquisition and partnerships that help them in strengthening their market position. For instance, in May 2017, the Drägerwerk AG & CO. KGAA introduced Oxylog VE300, a newly developed emergency and transport ventilator that is particularly apt for use outside of the hospital environment.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support